Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

  • This share is currently suspended. It was suspended at a price of 13.50
  • There is currently no data for WCW

Working Capital Loan Extension & Trading Update

24 Nov 2025 07:00

RNS Number : 6524I
Walker Crips Group plc
24 November 2025
 

24 November 2025

 

Walker Crips Group plc

 

("Walker Crips", "Group" or the "Company")

 

Working Capital Loan Drawdown Facility Extension

 

Trading Update

 

Walker Crips announces an extension (the "Extension") to the £5m Working Capital Loan Drawdown Facility (the "Facility") with Phillip Brokerage Pte Ltd ("PhillipCapital") and provides an update on current trading and business operations.

 

This announcement should be read in conjunction with the announcement published at 7.00 a.m. today, regarding the recommended cash offer for the Company (the "Announcement") by PhilipCapital UK LTD, an indirect, wholly-owned subsidiary of Phillip Brokerage Pte Ltd (the "Acquisition"). Terms used in this announcement shall have the meaning given to them in the Announcement unless otherwise defined.

 

Working Capital Loan Drawdown Facility Extension

 

Under the existing terms of the Facility announced on 31 July 2025, if any amount of the £5 million Facility (including accrued but unpaid interest) is not repaid and therefore remains drawn down six months from the date of the agreement, the Company will be required to initiate a rights issue for the purpose of repayment of the Facility (the "Repayment Date").

 

It is currently anticipated that the Acquisition will become effective in Q1 2026. Therefore, the Company and PhillipCapital have agreed to extend the Repayment Date by one month, from 31 January 2026 to 28 February 2026 so as to allow time for the Acquisition to complete thus (absent of any other event occurring which would trigger repayment) removing the requirement to make repayment or commence a rights issue to repay any outstanding amounts under the Facility, prior to completion of the Acquisition.

 

Given that the Extension has been entered into to provide adequate time for the Acquisition to complete, the Extension is conditional upon:

· the Meetings being held prior to 31 January 2026; and

· the requisite majorities of shareholders of the Company voting in favour of the Scheme at the Court Meeting and voting in favour of the Resolution(s) at the General Meeting,

(each a "Condition" and together the "Conditions")

 

Should the requisite majorities of Shareholders not approve the Acquisition at the Court Meeting or General Meeting, the Acquisition will not be capable of progressing and therefore there would be no need for the Extension. Accordingly, in such circumstances the terms of the existing Facility would remain unchanged and the Company would be required to repay any outstanding amounts, or initiate a rights issue for the purpose of repaying any outstanding amounts, under the Facility by 31 January 2026.

 

 

Trading Update

 

As detailed in the Company's 2025 annual results announced on 31 July 2025, the growing complexity and breadth of the Group's service offerings have increased the resources required to monitor and regulate its fund management activities. Accordingly, the Walker Crips Board has commenced a comprehensive review of the business, including the operating structure, risk management processes, and an assessment of strategic options to strengthen the balance sheet.

 

As previously announced, the continuing costs of addressing historic legacy issues and the changed regulations relating to interest paid on clients' cash deposits have meaningful negative effects on the outlook for the current year's profits. Whilst management have continued to make changes to the Group's structure and cost base, the Walker Crips Board does not anticipate a near-term improvement in financial performance.

 

As disclosed in the Company's annual report and accounts for the year ended 31 March 2025, the Company identified a legacy systems issue that could have resulted in client statements being presented incorrectly in relation to equalisation and accumulation units. This information, if used for tax affairs, could have an impact to client tax liability. The Walker Crips Board launched an investigation into this matter in June 2025. This investigation is ongoing and further updates will be made as appropriate.

 

The Company expects to announce its results for the six month period to 30 September 2025, in December 2025. 

 

Additional information

 

PhillipCapital and its connected parties hold 12,359,803 shares in the Company, equivalent to 29.03% per cent. of the Company's issued share capital. As a result of its shareholding in the Company, PhillipCapital is defined as a related party under the UK Listing Rules ("UKLRs") and the Extension constitutes a related party transaction under paragraph 8.2.1R of the UKLRs.

 

The Board (comprised for these purposes of all directors with the exception of Hua Min Lim and Linus Lim) confirms its view that the Extension is fair and reasonable as far as the shareholders of Walker Crips are concerned and that the Board has been so advised by Singer Capital Markets in its role as the Company's sponsor in connection with the Extension.

 

 

For further information, please contact:

 

Walker Crips Group plc

Craig Harrison, Media Relations

Tel: +44 (0)20 3100 8000

Singer Capital Markets

Charles Leigh-Pemberton / Asha Chotai

Tel: +44 (0)20 7496 3000

 

 

Further information on Walker Crips Group is available on the Company's website: www.walkercrips.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLXLLLEFLEFBD
Date   Source Headline
3rd Mar 20265:15 pmRNSDisclosure Table
3rd Mar 202610:30 amRNSScheme Becomes Effective
27th Feb 202610:41 amRNSCourt Sanction of Scheme of Arrangement
26th Feb 20266:00 pmRNSWalker Crips Group
26th Feb 20264:00 pmRNSAnnouncement of Timing of Court Sanction Hearing
24th Feb 20267:30 amRNSAnnouncement of Court Sanction Hearing Location
10th Feb 20269:57 amRNSForm 8.5 (EPT/RI)
4th Feb 202610:45 amRNSUpdate on Timetable
3rd Feb 20269:02 amRNSSatisfaction of Regulatory Conditions
30th Jan 202610:35 amRNSForm 8.5 (EPT/RI) - Walker Crips Group plc
29th Jan 202611:53 amRNSForm 8.5 (EPT/RI)
28th Jan 202610:17 amRNSForm 8.5 (EPT/RI)
27th Jan 20269:50 amRNSForm 8.5 (EPT/RI)
26th Jan 202610:26 amRNSForm 8.5 (EPT/RI)
23rd Jan 202610:42 amRNSForm 8.5 (EPT/RI) - Walker Crips Group plc
19th Jan 202610:37 amRNSForm 8.5 (EPT/RI)
16th Jan 202611:37 amRNSForm 8.5 (EPT/RI)
15th Jan 20264:30 pmRNSResult of Meeting
15th Jan 202611:23 amRNSForm 8 (Opening Position Disclosure)
15th Jan 202610:05 amRNSForm 8.5 (EPT/RI)
14th Jan 202610:46 amRNSForm 8.5 (EPT/RI)
12th Jan 202610:06 amRNSForm 8.5 (EPT/RI)
9th Jan 202610:22 amRNSForm 8.5 (EPT/RI)
8th Jan 202610:36 amRNSForm 8.5 (EPT/RI)
7th Jan 202610:57 amRNSForm 8.5 (EPT/RI)
6th Jan 20269:57 amRNSForm 8.5 (EPT/RI) - Walker Crips Group plc
31st Dec 20257:00 amRNSResults for the six months ended 30 September 2025
31st Dec 20257:00 amRNSResults for the six months ended 30 September 2025
22nd Dec 202511:50 amRNSForm 8.3 - Walker Crips Group PLC
19th Dec 20257:00 amRNSForm 8.3 - Walker Crips Group plc
17th Dec 202512:59 pmRNSForm 8.3 Walker Crips Group PLC Replacement
16th Dec 20254:08 pmRNSForm 8.3 Walker Crips Group PLC
16th Dec 202510:32 amRNSReplacement: Publication of Scheme Document
16th Dec 202510:16 amRNSForm 8.3 - Walker Crips Group PLC
16th Dec 20259:49 amRNSForm 8.5 (EPT/RI)
15th Dec 202510:45 amRNSPublication & Posting of Scheme Document
12th Dec 20254:38 pmRNSForm 8.3 Replacement
12th Dec 20258:46 amRNSForm 8.3 - Walker Crips Group plc
10th Dec 202511:55 amRNSForm 8.3 - Walker Crips Group plc
9th Dec 20255:14 pmRNSForm 8.3 - Walker Crips Group plc
8th Dec 20254:01 pmRNSForm 8.5 (EPT/RI) Replacement
8th Dec 20254:00 pmRNSForm 8 (Opening Position Disclosure)
8th Dec 202511:00 amRNSForm 8 (Opening Position Disclosure)
5th Dec 20256:04 pmRNSForm 8.3 - Walker Crips Group plc
5th Dec 20251:52 pmRNSForm 8.3 - Walker Crips Group PLC
2nd Dec 20259:46 amRNSForm 8.5 (EPT/RI)
28th Nov 20259:28 amRNSForm 8.5 (EPT/RI)
27th Nov 202510:16 amRNSForm 8.5 (EPT/RI)
26th Nov 202510:18 amRNSForm 8.5 (EPT/RI)
25th Nov 20251:40 pmRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.